Overview

A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
To compare the time to response, response rates, remission rates, and side effects in Bipolar Disorder inpatients treated with Depakote ER or Depakote DR for acute mania or mixed mania.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Abbott
Treatments:
Valproic Acid